The authors concluded that there was insufficient evidence to determine the accuracy of computed tomographic (CT) pulmonary angiography for diagnosing pulmonary embolism (PE), but negative CT in combination with negative examination for deep vein thrombosis can exclude PE. This was a well-conducted and clearly reported review and the conclusions, though based on a small number of patients, are likely to be reliable.
Participants included in the review
The included studies were diagnostic accuracy studies of patients with suspected PE, or follow-up studies of patients with a negative CT result. The prevalence of PE ranged from 19 to 79% in the included diagnostic accuracy studies and from 10 to 35% in the follow-up studies. One study in patients with suspected massive PE and two studies in intensive care patients were excluded.
Outcomes assessed in the review
The included diagnostic accuracy studies were required to report the numbers of true-positive, false-positive, falsenegative and true-negative results for PE. The included follow-up studies had to report sufficient data to calculate the numbers of participants who developed deep vein thrombosis (DVT) or PE during follow-up. The review reported sensitivity and specificity for diagnostic accuracy studies and false-negative rate for follow-up studies.
How were decisions on the relevance of primary studies made? Two reviewers independently assessed all titles and abstracts identified through the database searches; all potentially relevant publications were retrieved in full. Two reviewers then assessed all potentially relevant papers, with any disagreements resolved by a third reviewer.
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Assessment of study quality
Two reviewers independently assessed the methodological quality of the included studies using predetermined criteria; any discrepancies were resolved by a third reviewer. The quality assessment criteria addressed the recruitment process and characteristics of the included participants, the prevalence of PE, and details of the CT scan. For diagnostic accuracy studies, interpretation of the reference standard blind to the CT result and vice versa was also assessed. For follow-up studies, the outcomes assessed, consistency of assessment across patients, details of additional investigations (including method of determining cause of death where appropriate) and length of follow-up were also assessed.
Data extraction
Three reviewers independently extracted the study results. For diagnostic accuracy studies, the numbers of true positives, false positives, false negatives and true negatives were extracted and used to calculate the sensitivity and specificity. For follow-up studies, the numbers of false-negative CT scans were calculated; false negatives were defined as positive venous ultrasound or pulmonary angiogram, high probability ventilation-perfusion scan, or death caused by PE.
Methods of synthesis
How were the studies combined?
The results of the included studies were displayed in forest plots and pooled estimates were calculated using a randomeffects model.
How were differences between studies investigated?
For diagnostic accuracy studies, the presence of a diagnostic threshold effect was assessed by calculating the Spearman correlation coefficient between sensitivity and specificity. The Breslow-Day test was used to examine heterogeneity in the results between studies. Subgroup analyses, based on participant characteristics and quality assessment scores, were used to investigate potential sources of heterogeneity.
Results of the review
Thirteen diagnostic accuracy studies (749 participants) and 11 follow-up studies (2,763 participants) were included.
Diagnostic accuracy (13 studies).
Twelve studies used pulmonary angiography as the reference standard; the thirteenth used a diagnostic algorithm. All but three studies used a single detector scanner. Twelve studies used more than one radiologist to interpret the CT scan; the other did not report numbers. Participant characteristics and quality assessment results varied widely. The sensitivity ranged from 53 to 100% and the specificity from 7% to 100%. The pooled estimates for sensitivity and specificity were 88.9% (95% confidence interval, CI: 82.0, 95.0) and 94.6% (95% CI: 91.3, 98.0), respectively, and there was significant between-study heterogeneity (p<0.005) which was not improved by any of the subgroup analyses. There was no evidence of a diagnostic threshold effect.
Prognostic value (11 follow-up studies).
The baseline characteristics of the participants and follow-up varied. Follow-up ranged from clinical examination at 6 weeks to 3 months to one telephone call at 6 months. Only four studies reported a uniform investigative process after negative CT. The false-negative rate was heterogeneous (p=0.000), ranging from 0.009 (95% CI: 0.002, 0.048) to 0.107 (95% CI: 0.085, 0.133), and heterogeneity was not reduced by either participant subgroup analyses or a sensitivity analysis in which studies with poor quality scores were removed. When false-negative rates were calculated for a combination of both negative CT angiography and negative investigation for DVT there was no evidence of significant between-study heterogeneity (p=0.382); the pooled estimate for the false-negative rate (5 studies) was 1.5% (95% CI: 1.0, 1.9).
